Last reviewed · How we verify
NCT02644564
Early Clinical Examination and Ultrasonography Screening of Acute Soft Tissue Shoulder Injuries
trial testing Ultrasonography in Soft Tissue Shoulder Injury in 120 participants. Completed in 16 October 2017.
17 October 2016
Quick facts
| Lead sponsor | Oslo University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 5 October 2015 |
| Primary completion | 17 October 2016 |
| Estimated completion | 16 October 2017 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Ultrasonography
Conditions studied
- Soft Tissue Shoulder Injury — all drugs for Soft Tissue Shoulder Injury →
- Rotator Cuff Tear — all drugs for Rotator Cuff Tear →
Sponsor
Oslo University Hospital
Who can join
40 and older, any sex, with Soft Tissue Shoulder Injury or Rotator Cuff Tear. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to determine whether the introduction of early ultrasonography screening will change the diagnostic spectrum of soft tissue shoulder injuries in patients aged forty years or more. We also want to study whether certain physical tests will be able to predict or rule out full-thickness tears of the rotator cuff (shoulder tendons) in the acute phase. Another purpose is to explore the course of soft tissue shoulder injuries over a year, as well as to compare the results to studies on the prevalence of rotator cuff full-thickness tears.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Interrater reliability of physical examination tests in the acute phase of shoulder injuries.
Schmidt M, Enger M, Pripp AH, Nordsletten L, et al · · 2021 · cited 4× · PMID 34503466 · DOI 10.1186/s12891-021-04659-x -
Physical examination tests in the acute phase of shoulder injuries with negative radiographs: a diagnostic accuracy study.
Enger M, Schmidt M, Nordsletten L, Moosmayer S, et al · · 2025 · cited 1× · PMID 40462009 · DOI 10.1186/s12891-025-08754-1
Verify or expand the search:
- PubMed search for NCT02644564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ultrasonography
Trials testing the same drug.
- NCT07406061 — Ultrasound Imaging of the Head, Neck, and Airway · not yet recruiting
- NCT07144501 — Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut. · NA · not yet recruiting
- NCT06492603 — Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients · not yet recruiting
- NCT02492932 — The Second Try During Landmark Approach of the Internal Jugular Vein: an Ultrasonographic Prelocation Study · NA · not yet recruiting
- NCT06778005 — Investigation of Ultrasonographic Measurements of Lower Extremity Nerves in Type 2 Diabetes Patients With Peripheral Pol · recruiting
Other Oslo University Hospital trials
Trials by the same sponsor.
- NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
- NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
- NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
- NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
- NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02644564 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
- Last refreshed: 1 November 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02644564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing